Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare (NHC) EBIT Margin: 2009-2025

Historic EBIT Margin for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to 7.94%.

  • National Healthcare's EBIT Margin rose 12400.0% to 7.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.0%, marking a year-over-year increase of 14500.0%. This contributed to the annual value of 6.56% for FY2024, which is 15500.0% up from last year.
  • According to the latest figures from Q3 2025, National Healthcare's EBIT Margin is 7.94%, which was up 12400.0% from 9.09% recorded in Q2 2025.
  • National Healthcare's 5-year EBIT Margin high stood at 9.09% for Q2 2025, and its period low was 1.51% during Q3 2022.
  • Its 5-year average for EBIT Margin is 5.38%, with a median of 5.24% in 2021.
  • In the last 5 years, National Healthcare's EBIT Margin crashed by -35600bps in 2022 and then skyrocketed by 32700bps in 2023.
  • Quarter analysis of 5 years shows National Healthcare's EBIT Margin stood at 3.23% in 2021, then grew by 6bps to 3.42% in 2022, then skyrocketed by 95bps to 6.69% in 2023, then grew by 0bps to 6.71% in 2024, then increased by 18bps to 7.94% in 2025.
  • Its EBIT Margin stands at 7.94% for Q3 2025, versus 9.09% for Q2 2025 and 8.23% for Q1 2025.